SCHEMBL7780581

SCHEMBL7780581

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)n[nH]c2C(F)(F)F)c(C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 9/20 0.52
PTGS1 P23219 5/20 0.49
PTGS2 P35354 5/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
MAP2K7 O14733 1/20 0.43
MAP2K4 P45985 1/20 0.43
PTGES O14684 2/20 0.42
PDPK1 O15530 2/20 0.42
HDAC3 O15379 1/20 0.42
CA12 O43570 1/20 0.42
PDE5A O76074 1/20 0.42
ABCB11 O95342 1/20 0.42
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX5 P09917 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777717 0.90 MAP2K7 (0.53) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL7779454 0.90 LRRK2 (0.45) LRRK2PTGS1PTGS2CYP2C9MAPT
SCHEMBL7780679 0.86 LRRK2 (0.53) LRRK2PTGS1PTGS2CA1CA2
SCHEMBL7777620 0.86 LRRK2 (0.60) LRRK2PTGS1PTGS2CA1CA2
SCHEMBL7779616 0.83 LRRK2 (0.64) LRRK2PTGS1PTGS2CA1CA2
SCHEMBL7780622 0.83 LRRK2 (0.57) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL8633926 0.81 MAPT (0.46) LRRK2PTGS1PTGS2CA1CA2
SCHEMBL7777855 0.81 LRRK2 (0.55) LRRK2PTGS1PTGS2MAP2K7MAP2K4
SCHEMBL7779612 0.80 PTGS2 (0.49) LRRK2PTGS1PTGS2
SCHEMBL7780586 0.80 LRRK2 (0.52) LRRK2PTGS1PTGS2MAP2K7MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed